Search Result "resistance to Imatinib."
Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 21-28
Author(s): Massimo Breccia, Giuliana Alimena
Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar
Analysis of Potential Circular RNAs in Regulating Imatinib Resistance ofGastrointestinal Stromal Tumor
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 9 Year: 2024 Page: 1371-1380
Author(s):
Molecular Dynamic Studies Unveil Potential Mechanisms of Resistance to Imatinib in BCR-ABL Mutants
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Tai-Sung Lee,Steven J. Potts,Maher Albitar
Doi: 10.2174/9781608059089114030011
Critical Update and Emerging Trends in Imatinib Treatment for Gastrointestinal Stromal Tumor
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 1 Year: 2007 Page: 43-48
Author(s): Ugo De Giorgi, Alberto Pupi, Gina Turrisi, Iolanda Montenora, Stefano Morini, Mozghan Fayyaz, Michele De Simone, Giammaria Fiorentini
Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2765-2770
Author(s): Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Piera La Cava, Nunziatina Parrinello, Luca Vanella, Fabio Stagno, Giuseppe A. Palumbo, Giovanni Li Volti, Francesco Di Raimondo
Imatinib Reduces the Vasculogenic Potential of Plastic Tumor Cells
Journal: Current Angiogenesis (Discontinued)
Volume: 1 Issue: 1 Year: 2012 Page: 64-71
Author(s): Yvette W.J. Paulis,Domenica Dinnes,Patricia M.M.B. Soetekouw,Peter J. Nelson,Stefan Burdach,Robert P. Loewe,Vivianne C.G. Tjan-Heijnen,Irene von Luettichau,Arjan W. Griffioen
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists
Journal: Current Molecular Pharmacology
Volume: 11 Issue: 2 Year: 2018 Page: 113-121
Author(s): Yi Zhao,Kaijin Wu,Yongfeng Wu,Elizabeth Melendez,Goar Smbatyan,David Massiello,Michael Kahn
Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor
Journal: Current Cancer Therapy Reviews
Volume: 1 Issue: 1 Year: 2005 Page: 93-108
Author(s): Jonathan C. Trent, Jheri Dupart, Wei Zhang
Mechanisms of Resistance to Imatinib in CML Patients: A Paradigm for the Advantages and Pitfalls of Molecularly Targeted Therapy
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 8 Year: 2006 Page: 645-657
Author(s): E. Ritchie, G. Nichols